Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


MEDTRONIC   FYE=4 (April)

Annual - Income Statement - Company Specific

Fiscal period2022202120202019201820172016201520142013
Period End Date4/30/20224/30/20214/30/20204/30/20194/30/20184/30/20174/30/20164/30/20154/30/20144/30/2013
Net Sales31,686.0030,117.0028,913.0030,557.0029,953.0029,710.0028,833.0020,261.0017,005.0016,590.00
Total Revenue31,686.0030,117.0028,913.0030,557.0029,953.0029,710.0028,833.0020,261.0017,005.0016,590.00
Cost of Products Sold10,145.0010,483.009,424.009,155.009,067.009,294.009,142.006,309.004,333.004,126.00
Amortization of intangible assets1,733.001,783.001,756.001,764.001,823.001,980.001,931.00733.00349.00331.00
Research and development expense2,746.002,493.002,331.002,330.002,256.002,193.002,224.001,640.001,477.001,557.00
Purchased in-process research and development charges--------------------
Selling, general and administrative expense10,292.0010,148.0010,109.0010,418.0010,238.0010,018.009,469.006,904.005,847.005,698.00
Restructuring charges60.00293.00118.00198.0030.00303.00290.00237.0078.00172.00
Acquisition-related items------------283.00550.00117.00(49.00)
Certain litigation charges, net95.00118.00313.00166.0061.00300.0026.0042.00770.00--
Non-recurring charges--------------------
Special charges--------------38.00(40.00)--
Gain on sale of businesses--------697.00----------
Other income (expense) net(862.00)(315.00)(71.00)(258.00)(535.00)(239.00)(107.00)(118.00)(181.00)--
Operating Profit5,752.004,484.004,791.006,268.006,640.005,383.005,361.003,766.003,813.00--
Interest expense--------------666.00379.00151.00
Interest income--------------(386.00)(271.00)(237.00)
Interest expense553.00925.001,092.001,444.001,146.001,094.001,386.00280.00108.00151.00
Special charges--------------------
Certain litigation charges------------------245.00
Investment loss------------(70.00)------
Interest income, net--------181.00313.00431.00------
Other income (expense) net318.00336.00356.00373.00----------(108.00)
Earnings before income taxes5,517.003,895.004,055.005,197.005,675.004,602.004,336.003,486.003,705.004,251.00
Provision for income taxes456.00265.00(751.00)547.002,580.00578.00798.00811.00640.00784.00
Current tax expense: U.S467.00287.00151.00579.002,899.00614.00440.001,128.00532.00509.00
Current tax expense: International599.00439.00375.00406.00796.00840.00835.00502.00248.00219.00
Deferred tax expense ( U.S(402.00)(625.00)(138.00)(310.00)45.00(399.00)(67.00)(705.00)(175.00)46.00
Deferred tax expense ( International(209.00)165.00(1,139.00)(128.00)(1,160.00)(477.00)(410.00)(114.00)35.0010.00
Tax expense recorded directly in shareholders" equity--------------------
Income (loss) from Continuing Operations--------------------
Earnings from discontinued operations--------------------
Discontinued operations- Physio-Control divestiture-related costs--------------------
Discontinued operations- Gain on sale of Physio-Control--------------------
Discontinued operations- Earnings from operations of Physio-Control--------------------
Net income5,062.003,630.004,806.004,650.003,095.004,024.003,538.002,675.00----
Net income (loss) attributable to noncontrolling interests22.0024.0017.0019.00(9.00)(4.00)--------
Net earnings allocable to Common Units5,039.003,606.004,789.004,631.003,104.004,028.003,538.002,675.003,065.003,467.00
Earnings from continuing operations (Basic)--------------------
EPS (BASIC): Earnings from discontinued operations--------------------
Net Earnings Per Share (Basic)3.752.683.573.442.292.922.512.443.063.40
Earnings from continuing operations (Diluted)--------------------
EPS (DILUTED): Earnings from discontinued operations--------------------
Net Earnings Per Share (Diluted)3.732.663.543.412.272.892.482.413.023.37
Weighted Average Shares Outstanding (Basic)1,342.401,344.901,340.701,346.401,356.701,378.901,409.601,095.501,002.101,019.30
Weighted Average Shares Outstanding (Diluted)1,351.401,354.001,351.101,357.501,368.201,391.401,425.901,109.001,013.601,027.50